Spectranetics to Host Second Quarter 2016 Conference Call on July 28, 2016
July 07 2016 - 8:00AM
The Spectranetics Corporation (Nasdaq:SPNC) today announced that
the Company will release second quarter 2016 financial results
after the market close on Thursday, July 28, 2016. Company
management will host a conference call beginning at 2:30 p.m.
Mountain Time (4:30 p.m. Eastern Time) on Thursday, July 28, 2016
to discuss the results.
The dial-in for the conference call is (877) 561-2747 for
domestic callers or (973) 409-9689 for international callers. The
Conference ID is 42100557. There will also be a live webcast of the
call on the investor relations section of the Company’s website at
www.spectranetics.com. The webcast will be available on the
Company’s website for 14 days following the completion of the
call.
About SpectraneticsThe Spectranetics
Corporation develops, manufactures, markets and distributes medical
devices used in minimally invasive procedures within the
cardiovascular system. The Company's products are available in over
65 countries and are used to treat arterial blockages in the heart
and legs and in the removal of pacemaker and defibrillator
leads.
The Company's Vascular Intervention (VI) products include a
range of laser catheters for ablation of blockages in arteries
above and below the knee, the AngioSculpt scoring balloon used in
both peripheral and coronary procedures, and the Stellarex
drug-coated balloon peripheral angioplasty platform, which received
European CE mark approval in December 2014. The Company also
markets support catheters to facilitate crossing of peripheral and
coronary arterial blockages, and retrograde access and guidewire
retrieval devices used in the treatment of peripheral arterial
blockages, including chronic total occlusions. The Company markets
aspiration and cardiac laser catheters to treat blockages in the
heart.
The Lead Management (LM) product line includes excimer laser
sheaths, dilator sheaths, mechanical sheaths and accessories for
the removal of pacemaker and defibrillator cardiac leads.
For more information, visit www.spectranetics.com.
Investor Relations Contacts
Zach Stassen
Investor.relations@spnc.com
(719) 447-2292
Michaella Gallina
Investor.relations@spnc.com
(719) 447-2417
The Spectranetics Corp. (MM) (NASDAQ:SPNC)
Historical Stock Chart
From Apr 2024 to May 2024
The Spectranetics Corp. (MM) (NASDAQ:SPNC)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about The Spectranetics Corp. (MM) (NASDAQ): 0 recent articles
More News Articles